Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Hong Kong Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.

10 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
950 Lee's Pharmaceutical Holdings	HK$1.39	0.7%	-7.3%	HK$818.5m	n/a	PE13x	n/a	2.2%
2161 JBM (Healthcare)	HK$1.84	-5.2%	100.0%	HK$1.5b	n/a	PE9.1x	n/a	6.0%
1061 Essex Bio-Technology	HK$2.78	-3.8%	18.8%	HK$1.6b	n/a	PE6x	n/a	4.3%
2566 Hangzhou Jiuyuan Gene Engineering	HK$6.82	-8.1%	n/a	HK$1.7b	n/a	PE12.2x	n/a	n/a
2348 Dawnrays Pharmaceutical (Holdings)	HK$1.21	2.5%	18.6%	HK$1.8b	n/a	PE3x	n/a	6.3%
2633 Jacobson Pharma	HK$1.01	9.8%	57.8%	HK$2.0b	n/a	PE7.9x	n/a	6.9%
1558 YiChang HEC ChangJiang Pharmaceutical	HK$9.72	-3.6%	5.8%	HK$8.6b	HK$13.80	PE4.9x	S2.0%	0%
6826 Shanghai Haohai Biological Technology	HK$26.70	-6.3%	-0.05%	HK$13.7b	HK$42.57	PE13.4x	E16.8%	3.2%
1681 Consun Pharmaceutical Group	HK$7.79	-0.1%	66.5%	HK$6.5b	HK$10.20	PE7.3x	E14.7%	7.4%
2877 China Shineway Pharmaceutical Group	HK$9.36	-8.9%	38.7%	HK$7.1b	HK$12.88	PE6x	E8.1%	6.0%

Page 1 of 1